Predictors of decompressive hemicraniectomy in malignant middle cerebral artery stroke

  • Saadat Kamran
  • Abdul Salam
  • Naveed Akhtar
  • Atlantic D’soza
  • Ashfaq Shuaib
Original Article
  • 23 Downloads

Abstract

Identification of factors in malignant middle cerebral artery (MMCA) stroke patients that may be useful in selecting patients for DHC. This study was a retrospective multicenter study of patients referred for DHC based on the criteria of the randomized control trials of DHC in MMCA stroke. Demographic, clinical, and radiology data were analyzed. Patients who underwent DHC were compared to those who survived without surgery. Two hundred three patients with MMCA strokes were identified: 137 underwent DHC, 47 survived without DHC, and 19 refused surgery and died. Multivariate analysis identified the following factors determining DHC in MMCA stroke: age < 55 years (OR 8.5, 95% CI 3.3–22.1, P < 0.001), MCA with involvement of additional vascular territories (anterior cerebral artery, posterior cerebral artery (OR 4.8, 95% CI 1.5–14.9, P = 0.007), septum pellucidum displacement ≥ 7.5 mm (OR 4.8, 95% CI 1.9–11.7, P = 0.001), diabetes (OR 3.7, 95% CI 1.3–10.6, P = 0.012), infarct growth rate (IGR) ml/h (OR 1.11, 95% CI 1.02–1.2, P = 0.015), and temporal lobe involvement (OR 2.5, 95% CI 1.01–6.1, P = 0.048). The internal validation of the multivariate logistic regression model using bootstrapping analysis showed marginal bias. Among patients with MMCA infarctions, an increased possibility of DHC is associated with younger age, MCA with additional infarction, septum pellucidum deviation of > 7.5 mm, diabetes, IGR, and temporal lobe involvement. The presence of these risk factors identifies those MMCA stroke patients who may require DHC. Bootstrapping analysis indicated the model is good enough to predict the outcome in general population.

Keywords

Middle cerebral artery Decompressive hemicraniectomy Infarct volume 

Notes

Compliance with ethical standards

The study adhered to the tenets of the declaration of Helsinki and was approved by the Institutional Review Board of Hamad Medical Corporation, Qatar (15246/15).

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Huttner HB, Schwab S (2009 Oct) Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol 8(10):949–958CrossRefPubMedGoogle Scholar
  2. 2.
    Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R (1996 Apr) “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53(4):309–315CrossRefPubMedGoogle Scholar
  3. 3.
    Gupta R, Connolly ES, Mayer S, Elkind MSV (2004 Feb) Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke J Cereb Circ 35(2):539–543CrossRefGoogle Scholar
  4. 4.
    Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W (1998 Sep) Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke J Cereb Circ 29(9):1888–1893CrossRefGoogle Scholar
  5. 5.
    Holtkamp M, Buchheim K, Unterberg A, Hoffmann O, Schielke E, Weber JR, Masuhr F (2001 Feb) Hemicraniectomy in elderly patients with space occupying media infarction: improved survival but poor functional outcome. J Neurol Neurosurg Psychiatry 70(2):226–228CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp H, Hacke W, DECIMAL, DESTINY, and HAMLET investigators (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6(3):215–222CrossRefPubMedGoogle Scholar
  7. 7.
    Kamran S, Akhtar N, Salam A, Alboudi A, Kamran K, Ahmed A, Khan RA, Mirza MK, Inshasi J, Shuaib A (2017) Revisiting hemicraniectomy: late decompressive hemicraniectomy for malignant middle cerebral artery stroke and the role of infarct growth rate. Stroke Res Treat 2017:1–8CrossRefGoogle Scholar
  8. 8.
    Kasner SE, Demchuk AM, Berrouschot J, Schmutzhard E, Harms L, Verro P, Chalela JA, Abbur R, McGrade H, Christou I, Krieger DW (2001) Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke J Cereb Circ 32(9):2117–2123CrossRefGoogle Scholar
  9. 9.
    Wang K-W, Chang W-N, Ho J-T, Chang H-W, Lui C-C, Cheng M-H, Hung KS, Wang HC, Tsai NW, Sun TK, Lu CH (2006 Jul) Factors predictive of fatality in massive middle cerebral artery territory infarction and clinical experience of decompressive hemicraniectomy. Eur J Neurol 13(7):765–771CrossRefPubMedGoogle Scholar
  10. 10.
    Serena J, Blanco M, Castellanos M, Silva Y, Vivancos J, Moro MA, Leira R, Lizasoain I, Castillo J, Davalos A (2005 Sep) The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke 36(9):1921–1926CrossRefPubMedGoogle Scholar
  11. 11.
    Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L (1999 Feb) Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 30(2):287–292CrossRefPubMedGoogle Scholar
  12. 12.
    Ropper AH, Shafran B (1984 Jan) Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 41(1):26–29CrossRefPubMedGoogle Scholar
  13. 13.
    Maramattom BV, Bahn MM, Wijdicks EFM (2004 Dec 14) Which patient fares worse after early deterioration due to swelling from hemispheric stroke? Neurology 63(11):2142–2145CrossRefPubMedGoogle Scholar
  14. 14.
    Manno EM, Nichols DA, Fulgham JR, Wijdicks EFM (2003 Feb) Computed tomographic determinants of neurologic deterioration in patients with large middle cerebral artery infarctions. Mayo Clin Proc 78(2):156–160CrossRefPubMedGoogle Scholar
  15. 15.
    Barber PA, Demchuk AM, Zhang J, Kasner SE, Hill MD, Berrouschot J, Schmutzhard E, Harms L, Verro P, Krieger D (2003) Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis Basel Switz 16(3):230–235CrossRefGoogle Scholar
  16. 16.
    Frank JI (1995 Jul) Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 45(7):1286–1290CrossRefPubMedGoogle Scholar
  17. 17.
    Thomalla G, Hartmann F, Juettler E, Singer OC, Lehnhardt F-G, Köhrmann M, Kersten JF, Krützelmann A, Humpich MC, Sobesky J, Gerloff C, Villringer A, Fiehler J, Neumann-Haefelin T, Schellinger PD, Röther J, for the Clinical Trial Net of the German Competence Network Stroke (2010 Oct) Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: a prospective multicenter observational study. Ann Neurol 68(4):435–445CrossRefPubMedGoogle Scholar
  18. 18.
    Oppenheim C, Samson Y, Manaï R, Lalam T, Vandamme X, Crozier S et al (2000 Sep) Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke J Cereb Circ 31(9):2175–2181CrossRefGoogle Scholar
  19. 19.
    Shaw CM, Alvord EC, Berry RG (1959) Swelling of the brain following ischemic infarction with arterial occlusion. Arch Neurol 1:161–177CrossRefPubMedGoogle Scholar
  20. 20.
    Hofmeijer J, Algra A, Kappelle LJ, van der Worp HB (2008) Predictors of life-threatening brain edema in middle cerebral artery infarction. Cerebrovasc Dis Basel Switz 25(1–2):176–184CrossRefGoogle Scholar
  21. 21.
    Pullicino PM, Alexandrov AV, Shelton JA, Alexandrova NA, Smurawska LT, Norris JW (1997 Oct) Mass effect and death from severe acute stroke. Neurology 49(4):1090–1095CrossRefPubMedGoogle Scholar
  22. 22.
    Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp H, Hacke W, DECIMAL, DESTINY, and HAMLET investigators (2007 Mar) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6(3):215–222CrossRefPubMedGoogle Scholar
  23. 23.
    Frank JI, Schumm LP, Wroblewski K, Chyatte D, Rosengart AJ, Kordeck C, Thisted RA, on behalf of the HeADDFIRST Trialists, HeADDFIRST Trialists, Bernardini G, Andrefsky J, Krieger D, Elkind M, Coplin W, Graffagnino C, Biller J, Wang D, Cruz-Flores S, Brock D, Demchuk A, Verro P, Frank J, Woo D, Suarez J, Pettigrew C, LaMonte M (2014) Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial. Stroke J Cereb Circ 45(3):781–787CrossRefGoogle Scholar
  24. 24.
    Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH (1995 Oct 4) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274(13):1017–1025CrossRefPubMedGoogle Scholar
  25. 25.
    Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES, Lev MH, Schwamm LH (2009 Jun 16) ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72(24):2104–2110CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Akhtar N, Salam A, Kamran S, Bourke P, Joseph S, Santos M, Khan R, Irfan F, Deleu D, Malik RA, Shuaib A (2016) Ethnic variation in acute cerebrovascular disease: analysis from the Qatar stroke registry. Eur Stroke J 1(3):231–241CrossRefGoogle Scholar
  27. 27.
    Wasay M, Khatri IA, Kaul S (2014 Mar) Stroke in South Asian countries. Nat Rev Neurol 10(3):135–143CrossRefPubMedGoogle Scholar
  28. 28.
    Li Y-P, Hou M-Z, Lu G-Y, Ciccone N, Wang X-D, Dong L et al (2017) Neurologic functional outcomes of decompressive hemicraniectomy versus conventional treatment for malignant middle cerebral artery infarction: a systematic review and meta-analysis. World Neurosurg 99:709–25.e3Google Scholar
  29. 29.
    Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard J-P, Boutron C, Couvreur G, Rouanet F, Touze E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG, on behalf of the DECIMAL Investigators (2007) Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL trial). Stroke J Cereb Circ 38(9):2506–2517CrossRefGoogle Scholar
  30. 30.
    Uhl E, Kreth FW, Elias B, Goldammer A, Hempelmann RG, Liefner M et al (2004) Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction. J Neurol Neurosurg Psychiatry 75(2):270–274PubMedPubMedCentralGoogle Scholar
  31. 31.
    Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB, HAMLET investigators (2009 Apr) Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 8(4):326–333CrossRefPubMedGoogle Scholar
  32. 32.
    Frank JI, Schumm LP, Wroblewski K, Chyatte D, Rosengart AJ, Kordeck C, Thisted RA, on behalf of the HeADDFIRST Trialists, HeADDFIRST Trialists, Bernardini G, Andrefsky J, Krieger D, Elkind M, Coplin W, Graffagnino C, Biller J, Wang D, Cruz-Flores S, Brock D, Demchuk A, Verro P, Frank J, Woo D, Suarez J, Pettigrew C, LaMonte M (2014 Mar) Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial. Stroke J Cereb Circ 45(3):781–787CrossRefGoogle Scholar
  33. 33.
    Wijdicks EFM, Schievink WI, McGough PF (1997 Oct 31) Dramatic reversal of the uncal syndrome and brain edema from infarction in the middle cerebral artery territory. Cerebrovasc Dis 7(6):349–352CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neuroscience Institute (Stroke Center of Excellence)Hamad Medical CorporationDohaQatar
  2. 2.Weill Cornell-MedicineAr-RayyanQatar

Personalised recommendations